We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$14.8B
AUM Growth
+$1.53B
Cap. Flow
+$575M
Cap. Flow %
3.88%
Top 10 Hldgs %
20.47%
Holding
2,662
New
208
Increased
1,251
Reduced
990
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 9.79%
2 Consumer Discretionary 5%
3 Healthcare 4.52%
4 Financials 4.2%
5 Communication Services 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKCC
2476
DELISTED
BlackRock Capital Investment Corporation
BKCC
$27K ﹤0.01%
+11,104
New +$29.3K
NAK
2477
Northern Dynasty Minerals
NAK
$953M
$25K ﹤0.01%
25,000
+10,000
+67% +$13.7K
TNXP icon
2478
Tonix Pharmaceuticals
TNXP
$205M
0
TXMD icon
2479
TherapeuticsMD
TXMD
$24.1M
$23K ﹤0.01%
296
-229
-44% -$18.3K
AUD
2480
DELISTED
Audacy, Inc.
AUD
$23K ﹤0.01%
13,985
+930
+7% +$1.39K
NBEV
2481
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$23K ﹤0.01%
13,110
-1,100
-8% -$2.14K
HEXO
2482
DELISTED
HEXO Corp. Common Shares
HEXO
$22K ﹤0.01%
590
-100
-14% -$3.99K
MFAC.WS
2483
DELISTED
Megalith Financial Acquisition Corp. Warrants, each warrant exercisable for one share of Class A Com
MFAC.WS
$22K ﹤0.01%
+32,800
New +$22K
OGI
2484
Organigram Holdings
OGI
$182M
$20K ﹤0.01%
4,634
+15
+0.3% +$78
GAU
2485
Galiano Gold
GAU
$546M
$19K ﹤0.01%
13,559
CRVO icon
2486
CervoMed
CRVO
$41.5M
$18K ﹤0.01%
277
+90
+48% +$6.84K
PR
2487
Permian Resources
PR
$18B
$18K ﹤0.01%
30,107
+957
+3% +$735
QEP
2488
DELISTED
QEP RESOURCES, INC.
QEP
$18K ﹤0.01%
19,491
AYTU icon
2489
AYTU BioPharma
AYTU
$25.3M
$17K ﹤0.01%
70
REI icon
2490
Ring Energy
REI
$354M
$17K ﹤0.01%
25,066
TTOO
2491
DELISTED
T2 Biosystems, Inc
TTOO
$16K ﹤0.01%
2
-1
-33% -$7.41K
TEUM
2492
DELISTED
Pareteum Corporation
TEUM
$15K ﹤0.01%
21,635
-400
-2% -$268
MARK
2493
DELISTED
Remark Holdings, Inc.
MARK
$14K ﹤0.01%
1,221
-1,049
-46% -$14.6K
TYME
2494
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$13K ﹤0.01%
13,000
GPL
2495
DELISTED
Great Panther Mining Limited
GPL
$13K ﹤0.01%
1,470
PULM icon
2496
Pulmatrix
PULM
$5.84M
$12K ﹤0.01%
510
PVL
2497
Permianville Royalty Trust
PVL
$57.8M
$12K ﹤0.01%
17,785
+4,000
+29% +$3.96K
KOS icon
2498
Kosmos Energy
KOS
$1.49B
$10K ﹤0.01%
10,139
-861
-8% -$1.26K
BNGO icon
2499
Bionano Genomics
BNGO
$13.8M
$8K ﹤0.01%
+19
New +$7.37K
SONM icon
2500
DNA X Inc
SONM
$5.16M
$8K ﹤0.01%
+6
New +$9.64K

Similar funds

Cambridge Investment Research Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Cambridge Investment Research Advisors held 2,662 positions worth $14.8B, up 12% from $13.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $575M of net new capital in Q3 2020, opening 208 new positions and adding to 1,251 existing holdings. Its largest new stake was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was C.H. Robinson, an estimated $26.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2020 buy was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
  • Cambridge Investment Research Advisors added most to Bristol-Myers Squibb in Q3 2020, an estimated $56.7M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2020 reduction was C.H. Robinson, cutting an estimated $26.2M.
  • Cambridge Investment Research Advisors fully exited WisdomTree International ESG Fund in Q3 2020, selling an estimated $11.4M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $14.8B portfolio in Q3 2020.
  • Cambridge Investment Research Advisors opened 208 new positions and closed 149 in Q3 2020.
  • Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $14.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.